ODYY News and Press, Odyssey Group International Inc

LAS VEGAS, NV / ACCESSWIRE / March 27, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) , formerly Odyssey Group International, Inc., (the "Company") a company focused on developing unique, life-enhancing medical products, recently filed its quarterly report for the quarter ended January 31, 2024. The ...

LAS VEGAS, NV / ACCESSWIRE / January 2, 2024 / Odyssey Health, Inc. (OTCQB:ODYY) ("Odyssey" or the "Company") today announces the closing of the definitive Asset Purchase Agreement, that was entered into on October 4, 2023, with Oragenics, Inc., (OGEN:NYSE American) under which Oragenics acquire...

2023-12-12 09:32:01 ET More on Odyssey Health, Inc. Financial information for Odyssey Health, Inc. For further details see: Odyssey Health gains shareholder approval for asset sale with Oragenics

LAS VEGAS, NV / ACCESSWIRE / December 12, 2023 / Odyssey Health, Inc. ( OTCOB:ODYY ), a company focused on developing unique, life-enhancing medical products including a drug treatment intended to treat concussion, announces that it has received stockholder approval for the sale of its neurologi...

2023-11-16 10:26:49 ET More on Odyssey Health, Inc. Financial information for Odyssey Health, Inc. For further details see: Odyssey selects Syneos Health to support its IND application for treatment of concussion

LAS VEGAS, NV / ACCESSWIRE / November 16, 2023 / Odyssey Health, Inc. ( OTCQB:ODYY ), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, has selected Syneos Health ® , a leading fully integrated biopharmaceutical solutions organ...

LAS VEGAS, NV / ACCESSWIRE / November 15, 2023 / Odyssey Health, Inc. (OTCQB:ODYY) , formerly Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, will hold a webcast to provide an update on the Company and recap its progress. The Webcast w...

LAS VEGAS, NV / ACCESSWIRE / October 18, 2023 / Odyssey Health, Inc. (OTCQB: ODYY ), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products is providing an update on its Asset Purchase Agreement with Oragenics, Inc. (NYSE: OGEN). When th...

2023-10-05 06:51:17 ET More on Oragenics Oragenics and Lantern Bioworks enter into a partnership Oragenics announces private placement Financial information for Oragenics For further details see: Oragenics to acquire certain assets of Odyssey Health

Gains Nasal Delivery Technologies and Expands Product Pipeline Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) and Odyssey Health, Inc. (OTCQB: ODYY ) (“Odyssey”) announce the signing of a definitive agreement under wh...